Processing your request


please wait...

Case Page

 

Case Status:    DISMISSED    
On or around 09/07/2017 (Stipulation and order of dismissal (voluntary dismissal))

Filing Date: May 25, 2017

Span-America Medical Systems, Inc. manufactures and distributes medical products for the consumer and industrial markets, specializing in polyurethane foam for health and skin care related treatments.

According to the Complaint, on May 1, 2017, the Company announced that it had entered into an agreement and
plan of merger, by which Savaria would commence a tender offer to acquire all of the outstanding shares of Span-America at a purchase price of $29.00 per share in cash (the “Proposed Transaction”). The Tender Offer is set to expire on June 15, 2017.

In connection with the commencement of the Tender Offer, on May 17, 2017, the Company filed a Recommendation Statement on Schedule 14D-9 with the SEC. The Complaint alleges the Recommendation Statement is materially deficient and misleading because it fails to disclose material information about the financial projections prepared by the Company and relied upon by the Company’s financial advisor, and potential conflicts of interest regarding Span-America’s managers and directors.

This case was voluntarily dismissed as Moot on July 7, 2017.

Protected Content


Please Log In or Sign Up for a free account to access restricted features of the Clearinghouse website, including the Advanced Search form and the full case pages.

When you sign up, you will have the option to save your search queries performed on the Advanced Search form.